Cargando…
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090889/ https://www.ncbi.nlm.nih.gov/pubmed/36716004 http://dx.doi.org/10.2337/dc22-1952 |
| _version_ | 1785023052879233024 |
|---|---|
| author | Ryder, Robert E.J. Laubner, Katharina Benes, Marek Haluzik, Martin Munro, Lynne Frydenberg, Harry Teare, Julian P. Ruban, Aruchuna Fishman, Sigal Santo, Erwin Stengel, Rainer De Jonge, Charlotte Greve, Jan W. Cohen, Ricardo V. Aboud, Cristina M. Holtmann, Gerald J. Rich, Graeme McMaster, Jess J. Battelino, Tadej Kotnik, Primoz Byrne, James P. Mason, John C. Bessell, Justin Bascomb, Jeanine Kow, Lillian Collins, Janes Chisholm, Jacob Pferschy, Peter N. Sourij, Harald Cull, Melissa L. Wyres, Melanie C. Drummond, Russell McGowan, Barbara Amiel, Stephanie A. Yadagiri, Mahi Sen Gupta, Piya Aberle, Jens Seufert, Jochen |
| author_facet | Ryder, Robert E.J. Laubner, Katharina Benes, Marek Haluzik, Martin Munro, Lynne Frydenberg, Harry Teare, Julian P. Ruban, Aruchuna Fishman, Sigal Santo, Erwin Stengel, Rainer De Jonge, Charlotte Greve, Jan W. Cohen, Ricardo V. Aboud, Cristina M. Holtmann, Gerald J. Rich, Graeme McMaster, Jess J. Battelino, Tadej Kotnik, Primoz Byrne, James P. Mason, John C. Bessell, Justin Bascomb, Jeanine Kow, Lillian Collins, Janes Chisholm, Jacob Pferschy, Peter N. Sourij, Harald Cull, Melissa L. Wyres, Melanie C. Drummond, Russell McGowan, Barbara Amiel, Stephanie A. Yadagiri, Mahi Sen Gupta, Piya Aberle, Jens Seufert, Jochen |
| author_sort | Ryder, Robert E.J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10090889 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100908892023-04-13 Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide Ryder, Robert E.J. Laubner, Katharina Benes, Marek Haluzik, Martin Munro, Lynne Frydenberg, Harry Teare, Julian P. Ruban, Aruchuna Fishman, Sigal Santo, Erwin Stengel, Rainer De Jonge, Charlotte Greve, Jan W. Cohen, Ricardo V. Aboud, Cristina M. Holtmann, Gerald J. Rich, Graeme McMaster, Jess J. Battelino, Tadej Kotnik, Primoz Byrne, James P. Mason, John C. Bessell, Justin Bascomb, Jeanine Kow, Lillian Collins, Janes Chisholm, Jacob Pferschy, Peter N. Sourij, Harald Cull, Melissa L. Wyres, Melanie C. Drummond, Russell McGowan, Barbara Amiel, Stephanie A. Yadagiri, Mahi Sen Gupta, Piya Aberle, Jens Seufert, Jochen Diabetes Care e-Letters – Observations American Diabetes Association 2023-04 2023-01-30 /pmc/articles/PMC10090889/ /pubmed/36716004 http://dx.doi.org/10.2337/dc22-1952 Text en © 2023 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
| spellingShingle | e-Letters – Observations Ryder, Robert E.J. Laubner, Katharina Benes, Marek Haluzik, Martin Munro, Lynne Frydenberg, Harry Teare, Julian P. Ruban, Aruchuna Fishman, Sigal Santo, Erwin Stengel, Rainer De Jonge, Charlotte Greve, Jan W. Cohen, Ricardo V. Aboud, Cristina M. Holtmann, Gerald J. Rich, Graeme McMaster, Jess J. Battelino, Tadej Kotnik, Primoz Byrne, James P. Mason, John C. Bessell, Justin Bascomb, Jeanine Kow, Lillian Collins, Janes Chisholm, Jacob Pferschy, Peter N. Sourij, Harald Cull, Melissa L. Wyres, Melanie C. Drummond, Russell McGowan, Barbara Amiel, Stephanie A. Yadagiri, Mahi Sen Gupta, Piya Aberle, Jens Seufert, Jochen Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide |
| title | Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide |
| title_full | Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide |
| title_fullStr | Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide |
| title_full_unstemmed | Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide |
| title_short | Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide |
| title_sort | endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide |
| topic | e-Letters – Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090889/ https://www.ncbi.nlm.nih.gov/pubmed/36716004 http://dx.doi.org/10.2337/dc22-1952 |
| work_keys_str_mv | AT ryderrobertej endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT laubnerkatharina endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT benesmarek endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT haluzikmartin endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT munrolynne endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT frydenbergharry endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT tearejulianp endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT rubanaruchuna endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT fishmansigal endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT santoerwin endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT stengelrainer endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT dejongecharlotte endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT grevejanw endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT cohenricardov endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT aboudcristinam endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT holtmanngeraldj endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT richgraeme endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT mcmasterjessj endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT battelinotadej endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT kotnikprimoz endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT byrnejamesp endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT masonjohnc endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT besselljustin endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT bascombjeanine endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT kowlillian endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT collinsjanes endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT chisholmjacob endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT pferschypetern endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT sourijharald endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT cullmelissal endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT wyresmelaniec endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT drummondrussell endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT mcgowanbarbara endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT amielstephaniea endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT yadagirimahi endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT senguptapiya endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT aberlejens endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide AT seufertjochen endoscopicduodenaljejunalbypasslinertreatmentfortype2diabetesandobesityglycemicandcardiovasculardiseaseriskfactorimprovementsin1022patientstreatedworldwide |